Howe & Rusling Inc Gsk PLC Transaction History

Howe & Rusling Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 15, 2020	SELL	$37.87 - $43.58 $446,638 - $513,982	-11,794 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$32.47 - $48.83 $16,722 - $25,147	-515 Reduced 4.18%	11,794 $447,000
Q4 2019 Feb 05, 2020	BUY	$42.0 - $48.25 $3,570 - $4,101	85 Added 0.7%	12,309 $578,000
Q3 2019 Oct 31, 2019	BUY	$40.46 - $43.52 $8,092 - $8,704	200 Added 1.66%	12,224 $522,000
Q2 2019 Aug 12, 2019	SELL	$39.4 - $42.7 $8,628 - $9,351	-219 Reduced 1.79%	12,024 $481,000
Q1 2019 Apr 29, 2019	BUY	$38.57 - $42.69 $408,417 - $452,044	10,589 Added 640.21%	12,243 $512,000
Q3 2018 Nov 07, 2018	BUY	$39.75 - $42.69 $40,704 - $43,714	1,024 Added 162.54%	1,654 $66,000
Q1 2018 May 14, 2018	SELL	$36.18 - $40.15 $723 - $803	-20 Reduced 3.08%	630 $25,000
Q3 2017 Oct 18, 2017	BUY	$39.44 - $41.55 $25,636 - $27,007	650	650 $26,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.4B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Howe & Rusling Inc, based on Form 13F filings with the SEC.

Stay updated on Howe & Rusling Inc with notifications on news.